首页> The Journal of clinical investigation> Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.

Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.

导出 OA

翻译打印收藏纠错

第一作者： Supreet,Agarwal

第一单位： Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.

作者： Supreet,Agarwal ^[1] ; Lei,Fang ^[1] ; Kerry,McGowen ^[1] ; JuanJuan,Yin ^[1] ; Joel,Bowman ^[1] ; Anson T,Ku ^[1] ; Aian Neil,Alilin ^[1] ; Eva,Corey ^[2] ; Martine P,Roudier ^[2] ; Lawrence D,True ^[3] ; Ruth,Dumpit ^[4] ; Ilsa,Coleman ^[4] ; John K,Lee ^[4] ; Peter S,Nelson ^[4] ; Brian J,Capaldo ^[1] ; Aida,Mariani ^[5] ; Clare,Hoover ^[5] ; Ilya S,Senatorov ^[1] ; Michael,Beshiri ^[1] ; Adam G,Sowalsky ^[1] ; Elaine M,Hurt ^[5] ; Kathleen,Kelly ^[1]

作者单位： Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA. ^[1] Department of Urology and. ^[2] Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. ^[3] Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[4] AstraZeneca, Gaithersburg, Maryland, USA. ^[5]

关键词 Cell Biology Drug therapy Prostate cancer Therapeutics